Cite

HARVARD Citation

    Ahir, M. et al. (2020). Delivery of dual miRNA through CD44-targeted mesoporous silica nanoparticles for enhanced and effective triple-negative breast cancer therapy. Biomaterials science. pp. 2939-2954. [Online]. 
  
Back to record